| Authors: |
Hamilton BK; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Onstad L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Pidala J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Chen G; University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cutler C; Dana Farber Cancer Institute, Boston, Massachusetts, USA., El Jurdi N; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Farhadfar N; Sarah Cannon Transplant and Cellular Program, Methodist Hospital, San Antonio, Texas, USA., Juckett M; University of Minnesota, Minneapolis, Minnesota, USA., Kitko CL; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Lee CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. |
